(2026). A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata. Journal of Health Economics and Outcomes Research.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"A Cost-per-Responder Analysis of Ritlecitinib Vs Baricitinib in Severe Alopecia Areata."
Journal of Health Economics and Outcomes Research 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"A Cost-per-Responder Analysis of Ritlecitinib Vs Baricitinib in Severe Alopecia Areata."
Journal of Health Economics and Outcomes Research, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.